Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: JOHN W. who wrote (3676)	1/26/1998 10:24:00 PM
From: David S.	Read Replies (2) of 6136

Since John W. says that Agouron has the cure for the common cold, I thought you all would want to know that these firms are all biotech firms that should therefore be shorted since their work in developing biotech solutions for the common cold will obviously, be worthless since everything AGPH does turns to gold, uh...what happened to AGPH's psoriasis product, oh well - who cares about the small stuff anyway? Bayer BAYZ9700 Phase 1 Boehringer Soluble ICAM-1 Phase II Lilly LY354400 preclinical ViroPharma Pleconaril Phase II, colds in asthmatics By the way, what phase is AGPH's rhinovirus 3c protease inhibitor in, John? OK group, can you say "picornavirus"?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next